IL108308A0 - Polypeptides, their production and pharmaceutical compositions containing them - Google Patents

Polypeptides, their production and pharmaceutical compositions containing them

Info

Publication number
IL108308A0
IL108308A0 IL10830894A IL10830894A IL108308A0 IL 108308 A0 IL108308 A0 IL 108308A0 IL 10830894 A IL10830894 A IL 10830894A IL 10830894 A IL10830894 A IL 10830894A IL 108308 A0 IL108308 A0 IL 108308A0
Authority
IL
Israel
Prior art keywords
polypeptides
production
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL10830894A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939300510A external-priority patent/GB9300510D0/en
Priority claimed from GB939313129A external-priority patent/GB9313129D0/en
Priority claimed from GB939315561A external-priority patent/GB9315561D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL108308A0 publication Critical patent/IL108308A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL10830894A 1993-01-12 1994-01-10 Polypeptides, their production and pharmaceutical compositions containing them IL108308A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939300510A GB9300510D0 (en) 1993-01-12 1993-01-12 Improvements in or relating to organic compounds
GB939313129A GB9313129D0 (en) 1993-06-24 1993-06-24 Improvements in or relating to organic compounds
GB939315561A GB9315561D0 (en) 1993-07-28 1993-07-28 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
IL108308A0 true IL108308A0 (en) 1994-04-12

Family

ID=27266539

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10830894A IL108308A0 (en) 1993-01-12 1994-01-10 Polypeptides, their production and pharmaceutical compositions containing them

Country Status (11)

Country Link
EP (1) EP0607103A3 (cs)
JP (1) JPH06234792A (cs)
KR (1) KR940018397A (cs)
CA (1) CA2113121A1 (cs)
CZ (1) CZ5594A3 (cs)
FI (1) FI940109A7 (cs)
HU (1) HUT66294A (cs)
IL (1) IL108308A0 (cs)
NO (1) NO940080L (cs)
NZ (1) NZ250653A (cs)
SK (1) SK2094A3 (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
AU689626B2 (en) 1994-07-25 1998-04-02 Boehringer Mannheim Gmbh Peptides marked with metal chelates
GB9417873D0 (en) 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US6331285B1 (en) 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
JP2001513114A (ja) * 1997-11-24 2001-08-28 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ 放射性同位元素標識した化合物の組織への蓄積を促進するための方法
US7385025B2 (en) 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
JP2025532104A (ja) 2022-09-23 2025-09-29 ヌクリディウム アクチェンゲゼルシャフト 高純度銅放射性医薬組成物ならびにその診断および治療用途
TW202426433A (zh) 2022-09-23 2024-07-01 瑞士商紐利迪姆股份公司 成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0607103A2 (en) 1994-07-20
FI940109L (fi) 1994-10-11
EP0607103A3 (en) 1997-07-09
NO940080D0 (no) 1994-01-10
SK2094A3 (en) 1995-01-12
HUT66294A (en) 1994-11-28
JPH06234792A (ja) 1994-08-23
CA2113121A1 (en) 1994-07-13
FI940109A0 (fi) 1994-01-10
FI940109A7 (fi) 1994-10-11
NZ250653A (en) 1995-12-21
NO940080L (no) 1994-07-13
AU678778B2 (en) 1997-06-12
KR940018397A (ko) 1994-08-16
HU9400058D0 (en) 1994-05-30
CZ5594A3 (en) 1994-07-13
AU5309394A (en) 1994-07-21

Similar Documents

Publication Publication Date Title
IL106326A0 (en) Peptides, their production and pharmaceutical compositions containing them
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
IL106141A0 (en) Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them
IL110834A0 (en) Carboxamides, their preparation and pharmaceutical compositions containing them
IL89167A0 (en) Substituted pyrroles,their manufacture and pharmaceutical compositions containing them
IL119488A0 (en) Substituted 2,4-imidazolidinediones their production and pharmaceutical compositions containing them
HU9402974D0 (en) Pharmaceutical composition
IL89881A0 (en) Peptide derivatives,their production and pharmaceutical compositions containing them
IL108308A0 (en) Polypeptides, their production and pharmaceutical compositions containing them
IL108703A0 (en) Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them
IL102337A0 (en) Pyrrolpyrazines,their manufacture and pharmaceutical compositions containing them
GB9316580D0 (en) Pharmaceutical composition
PL314234A1 (en) Novel taxoides, their production and pharmaceutical composition containing them
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
IL110809A0 (en) 1,5-diphenyl-3-pyrazolylalkyl-n-hydroxydithiocarbamates and pharmaceutical compositions containing them
IL99294A0 (en) Indolonaphthyridines,their production and pharmaceutical compositions containing them
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
IL91003A0 (en) Proteins,their production and pharmaceutical compositions containing them
PL314036A1 (en) Pharmaceutical composition
IL91246A0 (en) Benzodiazepine compounds,their production and pharmaceutical compositions containing them
CA2100836A1 (en) Pharmaceutical composition
IL111216A0 (en) Heteroarylpiperidines, their preparation and pharmaceutical compositions containing them
IL99009A0 (en) Polypeptides,their preparation and pharmaceutical compositions containing them
ZA945752B (en) Pharmaceutical composition
IL91002A0 (en) Modified proteins,their production and pharmaceutical compositions containing them